Ikarian Capital, LLC Celldex Therapeutics, Inc. Put Options Transaction History

Ikarian Capital, LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$32.06 - $44.56 $9.79 Million - $13.6 Million	305,500 New	305,500 $10.4 Million
Q4 2023 Feb 14, 2024	SELL	$22.61 - $40.65 $17,432 - $31,341	-771 Reduced 79.4%	200 $7,000
Q3 2023 Nov 14, 2023	BUY	$25.45 - $37.46 $24,711 - $36,373	971 New	971 $26,000
Q1 2023 May 15, 2023	BUY	$34.78 - $47.43 $3.83 Million - $5.22 Million	110,000 New	110,000 $3.96 Million
Q2 2022 Aug 12, 2022	BUY	$20.5 - $37.33 $434,600 - $791,396	21,200 Added 3.56%	616,700 $16.6 Million
Q1 2022 May 13, 2022	BUY	$27.64 - $39.32 $3.99 Million - $5.67 Million	144,300 Added 31.98%	595,500 $20.3 Million
Q4 2021 Feb 14, 2022	SELL	$35.68 - $56.27 $2.46 Million - $3.88 Million	-69,000 Reduced 13.26%	451,200 $17.4 Million
Q3 2021 Nov 15, 2021	BUY	$28.95 - $55.99 $14.6 Million - $28.2 Million	504,200 Added 3151.25%	520,200 $28.1 Million
Q2 2021 Aug 16, 2021	BUY	$20.71 - $35.37 $331,360 - $565,920	16,000 New	16,000 $535,000

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.21B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.